Longevity & Aging
IDO1 inhibition (blocking tryptophan->kynurenine) restores astrocyte glycolysis and rescues memory across amyloid and tau Alzheimer's models
In plain terms: Can blocking an enzyme (IDO1) that both amyloid and tau switch on rescue memory in Alzheimer's models?
One strong mouse/cell study (Science 2024) shows amyloid and tau activate astrocytic IDO1->kynurenine, choking brain glucose use, and that blocking IDO1 restores memory; independent data confirm kynurenine pathway disturbance in human AD but the memory-rescue causal claim rests on this single lab.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
<!-- vault-context --> Norwitz **affirms** this claim. Consensus below reflects independent literature only.
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Minhas 2024 · Science | animal | supports | high | Cited paper: Abeta & tau activate astrocytic IDO1->KYN, suppressing glycolysis (AhR-dependent); IDO1 inhibition restores hippocampal LTP & memory across AD mouse models + AD-patient cocultures. |
| Bakker 2023 · Brain Behav Immun | observational | mixed | moderate | Plasma/CSF kynurenines relate variably to AD pathology markers; pathway altered but associations modest/inconsistent. |
| Cespedes 2022 · Neurobiol Dis | observational | supports | moderate | Systemic kynurenine-pathway perturbations precede progression to dementia independently of amyloid; human cohort, corroborates pathway relevance. |
| Dos Reis 2025 · Alzheimers Dement | observational | supports | moderate | Independent human data: kynurenine-pathway metabolite alterations in AD and Down-syndrome AD; corroborates pathway, not the intervention. |
| Souza 2016 · Brain Behav Immun | animal | supports | moderate | IDO inhibitor 1-MT prevented memory and emotional deficits after intracerebroventricular amyloid-beta in mice. |
| Zhang 2026 · Horm Behav | animal | supports | moderate | In APP/PS1 female mice, IDO1 inhibitor 1-MT reversed cognitive impairment and normalized Trp/Kyn metabolism. |
| Qian 2021 · Theranostics | animal | contradicts | moderate | Directional wrinkle: AhR ACTIVATION (not inhibition) rescues AD-mouse cognition via neprilysin; complicates the IDO1->KYN->AhR-as-harmful framing. |
| Almulla 2022 · J Alzheimers Dis | meta-analysis | supports | moderate | Meta-analysis: kynurenine/TRYCAT pathway is dysregulated in AD; supports the upstream premise (KYN disturbance) but not the IDO1-inhibition memory rescue. |
| Souza 2017 · Behav Brain Res | animal | supports | low | Swimming exercise reduced IDO/kynurenine activation and improved amyloid-beta-induced behavioral disturbances in mice, implicating IDO1 in cognitive impairment. |
| Minhas 2024 · bioRxiv | animal | supports | moderate | Preprint of the Science study showing IDO1 inhibition restores hippocampal glucose metabolism and rescues memory across amyloid and tau models. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.